What are the effects of hydrochloric acid ligustrazine injection?
Hydrochloric acid chuanxiongqin injection has the effects of reducing blood viscosity, dilating coronary arteries, improving microcirculation, treating platelet aggregation, treating myocardial infarction, etc. When injecting, it is necessary to change the injection site in time to avoid the occurrence of phlebitis. This drug is generally used to treat cardiovascular and cerebrovascular diseases.
1. Hydrochloric acid chuanxiongqin injection needs intravenous administration, mainly used to treat occlusive cerebrovascular diseases, such as cerebral thrombosis, cerebral insufficiency, coronary heart disease, vasculitis, etc. The drug effect is particularly accurate, reducing the harm caused by brain diseases. Patients should use this drug according to the doctor's advice. It should be noted that patients with cerebral hemorrhage and bleeding tendency should be prohibited from using this drug for treatment.
2. The main component of hydrochloric acid chuanxiongqin injection is hydrochloric acid chuanxiongqin, which is used to treat brain diseases, such as cerebral thrombosis, cerebral insufficiency, cerebral embolism, etc. It can also be used to treat coronary heart disease and vasculitis when necessary. Its drug effect has been recognized by everyone. This product needs intravenous administration. When used to treat ischemic cerebrovascular diseases, intravenous infusion is required. Dilute the drug in glucose injection or sodium chloride injection, infuse it intravenously from the patient's veins, and the infusion speed should not be too fast. Use the drug once a day, and ten days can be regarded as a course of treatment.
3. Hydrochloric acid chuanxiongqin can also dilate small arteries, improve microcirculation and increase cerebral blood flow. Therefore, hydrochloric acid chuanxiongqin injection is widely used in cardiovascular and cerebrovascular diseases, such as ischemic cerebrovascular diseases, such as insufficient blood supply, cerebral thrombosis, cerebral embolism, and other ischemic vascular diseases, such as coronary heart disease, vasculitis, etc. The following patients need to be aware that those who are allergic to this product, have cerebral hemorrhage, or have a tendency to bleed should be contraindicated. Patients with cerebral edema should be cautious when using it, and it should not be used in combination with alkaline drugs for intravenous drip. In addition, the intravenous drip speed of hydrochloric acid chuanxiongqin injection should not be too fast.
